Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  ImmunoCellular Therapeutics Ltd    IMUC

Delayed Quote. Delayed  - 06/24 10:02:03 pm
0.2394 USD   -0.33%
06/07 IMMUNOCELLULAR : Treats First Patient in ICT-107 Phase 3 Registrati..
05/23 IMMUNOCELLULAR : to Present at Marcum MicroCap Conference on June 2..
05/19 IMMUNOCELLULAR : BioLife Solutions and MNX Global Logistics Partner..
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
06/20/2016 06/21/2016 06/22/2016 06/23/2016 06/24/2016 Date
0.2516(c) 0.2518(c) 0.2401(c) 0.2402(c) 0.2394(c) Last
117 631 318 284 458 281 163 403 389 175 Volume
+4.75% +0.08% -4.65% +0.04% -0.33% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -24,8 M
Net income 2016 -25,8 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -26,3 M
Net income 2017 -27,4 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 0
Capi. / Sales2017 0
Capitalization 22,3 M
More Financials
Company
ImmunoCellular Therapeutics Ltd. is a Los Angeles-based clinical-stage company that develops immune-based therapies for the treatment of brain and other cancers.ImmunoCellular's pipeline includes: ICT-121, a dendritic cell immunotherapy targeting the CD133 antigen on stem cells in recurrent... 
More about the company
Latest news on IMMUNOCELLULAR THERAPEUTIC
06/21 IMMUNOCELLULAR THERAPEUTICS, LTD. : Submission of Matters to a Vote of Security ..
06/16 IMMUNOCELLULAR THERAPEUTICS : Treats First Patient in ICT-107 Phase 3 Registrati..
06/07 IMMUNOCELLULAR THERAPEUTICS, LTD. : Other Events (form 8-K)
06/07 IMMUNOCELLULAR THERAPEUTICS : Treats First Patient in ICT-107 Phase 3 Registrati..
05/23 IMMUNOCELLULAR THERAPEUTICS : to Present at Marcum MicroCap Conference on June 2..
05/19 IMMUNOCELLULAR THERAPEUTICS : Announces First Quarter 2016 Financial Results
05/19 IMMUNOCELLULAR THERAPEUTICS : BioLife Solutions and MNX Global Logistics Partner..
05/13 IMMUNOCELLULAR THERAPEUTICS : Management's Discussion and Analysis of Financial ..
05/12 IMMUNOCELLULAR THERAPEUTICS, LTD. : Results of Operations and Financial Conditio..
05/12 IMMUNOCELLULAR THERAPEUTICS : Announces First Quarter 2016 Financial Results
More news
Sector news : Biotechnology & Medical Research - NEC
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
06/24 MEDIVATION : Glass Lewis Recommends Medivation’s Stockholders Support the ..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
06/07 ImmunoCellular's late-stage study of lead product candidate in glioblastoma c..
05/12 ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q1 2016 Results - Ea..
05/12 ImmunoCellular Therapeutics beats by $0.01
03/31 ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q4 2015 Results - Ea..
03/31 ImmunoCellular Therapeutics reports FY15 results
Advertisement
Chart IMMUNOCELLULAR THERAPEUTIC
Duration : Period :
ImmunoCellular Therapeutic Technical Analysis Chart | IMUC | US4525361055 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions